Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease
NCT02689986
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
43
Enrollment
OTHER
Sponsor class
Conditions
Cold Agglutinin Disease
Autoimmune Hemolytic Anemia
Interventions
DRUG:
Bendamustine, Rituximab
Sponsor
Helse Fonna